Plandaí Biotechnology (PLPL) 10-Q2015 Q1 Quarterly report

Filed: 14 Nov 14, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: absorption, accrual, acquiree, Added, agreed, Alzheimer, animal, antioxidant, Bonakado, bringing, cannabinoid, chemical, clear, clinical, consumption, contracted, CRS, cultivated, demonstrated, demonstrating, deposited, dosage, enable, enlist, epilepsy, excellent, exercised, factor, FDA, field, format, found, fourth, ft, healthcare, human, initial, intangible, intention, introduced, investigative, invoice, laboratory, leaf, leaving, legal, medicinal, merged, meriting, model, neural, nutritive, online, oral, owed, Parkinson, penalty, permit, pertaining, Pheroid, phytonutrient, possessing, Potchefstroom, promising, psychoactive, published, red, reevaluated, refund, reorganization, requested, research, running, source, sourced, sq, strike, sublet, suspected, syndrome, synthetic, unaffiliated, University, user, varying, VAT, verbal, voluntary, wholly, writing

Removed: absorb, body, closed, commenced, computed, debenture, decided, dissolve, dividend, documented, easily, forgiven, holder, line, manager, minimum, mutual, negligible, nutraceutical, office, officially, option, par, repaid, restoring, roughly, satisfied, satisfy, scientific, space, Subscription, unnecessary

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

PLPL similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Plandai Biotechnology, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

November 14, 2014

/s/ Roger Duffield
Roger Duffield, President
(Principal Executive Officer)

November 14, 2014

/s/ Roger Duffield
Roger Duffield, Chief Financial Officer
(Principal Financial and Accounting Officer)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.